Serum Institute of India

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Serum Institute of India Private Limited
FounderCyrus S. Poonawalla
HeadquartersPune, India
Key people
Cyrus S. Poonawalla (Chairman & MD)
RevenueIncrease US$595 million (2015)
Increase US$295 million (2015)
Websitewww.seruminstitute.com/ Edit this on Wikidata

Serum Institute of India Private Limited[1][2] is a manufacturer of immunobiological drugs including vaccines in India. The company is managed by the Poonawalla group which fully owned by Cyrus Poonawalla. The company was founded by Poonawalla in 1966.[3] It is the world's largest vaccine producer by number of doses produced.[4] The company is developing an intra-nasal swine flu vaccine.[5] Co-developed with US-based Mass Biologics of the University of Massachusetts Medical School, it invented a fast-acting anti-rabies agent, Rabies Human Monoclonal Antibody (RMAb).[6]

References[edit]

  1. ^ "Serum Institute of India Pvt. Ltd.: Private Company Information". bloomberg.com. Retrieved 2018-09-30.
  2. ^ "SERUM INSTITUTE OF INDIA PRIVATE LIMITED - Company, directors and contact details". zaubacorp.com. Retrieved 2018-09-30.
  3. ^ "About Us". Serum Institute of India. Retrieved 8 December 2016.
  4. ^ "Cyrus Poonawalla on Forbes Lists". Forbes. Retrieved 24 March 2015.
  5. ^ "'India developing indigenous swine flu vaccine'". The Times of India. Retrieved 1 February 2015.
  6. ^ "Fast-acting anti-rabies drug set for India launch - Times of India". The Times of India. Retrieved 2016-06-12.

External links[edit]